3 Results for "

CDK2-IN-25

" in MedChemExpress (MCE) Product Catalog:
Products (3)

3 Results for "CDK2-IN-25" in MCE Product Catalog:

Cat. No.: HY-161291
Target:  

CDK

Research Areas:  

Cancer

CDK2-IN-25 (compound 7e) is a CDK2 inhibitor with an IC50 of 0.149 μM .
loading...
    loading...
2
2 Cited Publications
Cat. No.: HY-N7045
CAS No.: 142796-22-3
Isosilybin B is a flavonolignan. Isosilybin B can be isolated from Silybum marianum. Isosilybin B can regulate cell cycle-related proteins (e.g., reduce cyclins (D3, D1, A, E), Cdk4, Cdk2, Cdc25A), and activate Caspases (Caspase-9 and Caspase-3). Isosilybin B can promote Apoptosis, reduce androgen receptor (AR) and PSA. Isosilybin B has anticancer activity against prostate cancer .
loading...
    loading...
Cat. No.: HY-N7045R
CAS No.: 142796-22-3
Isosilybin B (Standard) is the analytical standard of Isosilybin B (HY-N7045). This product is intended for research and analytical applications. Isosilybin B is a flavonolignan. Isosilybin B can be isolated from Silybum marianum. Isosilybin B can regulate cell cycle-related proteins (e.g., reduce cyclins (D3, D1, A, E), Cdk4, Cdk2, Cdc25A), and activate Caspases (Caspase-9 and Caspase-3). Isosilybin B can promote Apoptosis, reduce androgen receptor (AR) and PSA. Isosilybin B has anticancer activity against prostate cancer .
loading...
    loading...